Share-based Payment Arrangement, Expense of ATOSSA THERAPEUTICS, INC. from 31 Dec 2012 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
ATOSSA THERAPEUTICS, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2012 to 30 Sep 2025.
  • ATOSSA THERAPEUTICS, INC. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $784,000, a 4.7% increase year-over-year.
  • ATOSSA THERAPEUTICS, INC. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $2,917,000, a 43% increase year-over-year.
  • ATOSSA THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2024 was $2,292,000, a 50% decline from 2023.
  • ATOSSA THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2023 was $4,621,000, a 32% decline from 2022.
  • ATOSSA THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2022 was $6,788,000, a 29% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

ATOSSA THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,917,000 $784,000 +$35,000 +4.7% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $2,882,000 $796,000 +$444,000 +126% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $2,438,000 $563,000 +$146,000 +35% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $2,292,000 $774,000 +$255,000 +49% 01 Oct 2024 31 Dec 2024 10-K 25 Mar 2025 2024 FY
Q3 2024 $2,037,000 $749,000 -$177,000 -19% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $2,214,000 $352,000 -$1,251,000 -78% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $3,465,000 $417,000 -$1,156,000 -73% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $4,621,000 $519,000 -$1,026,000 -66% 01 Oct 2023 31 Dec 2023 10-K 25 Mar 2025 2024 FY
Q3 2023 $5,647,000 $926,000 -$740,000 -44% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $6,387,000 $1,603,000 -$168,000 -9.5% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 $6,555,000 $1,573,000 -$233,000 -13% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q4 2022 $6,788,000 $1,545,000 -$74,000 -4.6% 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $6,862,000 $1,666,000 -$128,000 -7.1% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $6,990,000 $1,771,000 +$557,000 +46% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $6,433,000 $1,806,000 +$1,166,000 +182% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $5,267,000 $1,619,000 +$987,829 +157% 01 Oct 2021 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 $4,279,171 $1,794,000 +$1,130,407 +170% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022 2022 Q3
Q2 2021 $3,148,764 $1,214,000 +$177,516 +17% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2022 Q2
Q1 2021 $2,971,248 $640,000 -$47,752 -6.9% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 $3,019,000 $631,171 -$124,666 -16% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $3,143,666 $663,593 -$88,059 -12% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $3,231,725 $1,036,484 -$4,282,312 -81% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021 2021 Q2
Q1 2020 $7,514,037 $687,752 +$411,919 +149% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q1
Q4 2019 $7,102,118 $755,837 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 $751,652 +$419,589 +126% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020 2020 Q3
Q2 2019 $5,318,796 +$5,139,746 +2871% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2020 Q2
Q1 2019 $275,833 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
Q3 2018 $332,063 +$107,809 +48% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019 2019 Q3
Q2 2018 $179,050 -$2,358 -1.3% 01 Apr 2018 30 Jun 2018 10-Q 13 Aug 2019 2019 Q2
Q4 2017 $786,550 $226,181 +$25 +0.01% 01 Oct 2017 31 Dec 2017 10-K 28 Mar 2019 2018 FY
Q3 2017 $786,525 $224,254 -$33,135 -13% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 $819,660 $181,408 -$18,779 -9.4% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 $838,439 $154,707 -$37,750 -20% 01 Jan 2017 31 Mar 2017 10-Q 11 May 2017 2017 Q1
Q4 2016 $876,189 $226,156 +$58,020 +35% 01 Oct 2016 31 Dec 2016 10-K 08 Mar 2018 2017 FY
Q3 2016 $818,169 $257,389 -$60,597 -19% 01 Jul 2016 30 Sep 2016 10-Q 13 Nov 2017 2017 Q3
Q2 2016 $878,766 $200,187 -$4,925 -2.4% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017 2017 Q2
Q1 2016 $883,691 $192,457 +$43,588 +29% 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017 2017 Q1
Q4 2015 $840,103 $168,136 +$156,962 +1405% 01 Oct 2015 31 Dec 2015 10-K/A 21 Mar 2017 2016 FY
Q3 2015 $683,141 $317,986 +$170,587 +116% 01 Jul 2015 30 Sep 2015 10-Q/A 21 Mar 2017 2016 Q3
Q2 2015 $512,554 $205,112 +$37,578 +22% 01 Apr 2015 30 Jun 2015 10-Q/A 21 Mar 2017 2016 Q2
Q1 2015 $474,976 $148,869 -$81,312 -35% 01 Jan 2015 31 Mar 2015 10-Q/A 21 Mar 2017 2016 Q1
Q4 2014 $556,288 $11,174 01 Oct 2014 31 Dec 2014 10-K 30 Mar 2016 2015 FY
Q3 2014 $147,399 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015 2015 Q3
Q2 2014 $167,534 01 Apr 2014 30 Jun 2014 10-Q 06 Aug 2015 2015 Q2
Q1 2014 $230,181 01 Jan 2014 31 Mar 2014 10-Q 13 May 2015 2015 Q1

ATOSSA THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,292,000 -$2,329,000 -50% 01 Jan 2024 31 Dec 2024 10-K 25 Mar 2025 2024 FY
2023 $4,621,000 -$2,167,000 -32% 01 Jan 2023 31 Dec 2023 10-K 25 Mar 2025 2024 FY
2022 $6,788,000 +$1,521,000 +29% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $5,267,000 +$2,248,000 +74% 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2023 2022 FY
2020 $3,019,000 -$4,083,118 -57% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2022 2021 FY
2019 $7,102,118 +$6,048,622 +574% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
2018 $1,053,496 +$266,946 +34% 01 Jan 2018 31 Dec 2018 10-K 26 Mar 2020 2019 FY
2017 $786,550 -$89,639 -10% 01 Jan 2017 31 Dec 2017 10-K 28 Mar 2019 2018 FY
2016 $876,189 +$36,086 +4.3% 01 Jan 2016 31 Dec 2016 10-K 08 Mar 2018 2017 FY
2015 $840,103 +$283,815 +51% 01 Jan 2015 31 Dec 2015 10-K/A 21 Mar 2017 2016 FY
2014 $556,288 -$887,472 -61% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016 2015 FY
2013 $1,443,760 $0 0% 01 Jan 2013 31 Dec 2013 10-K 30 Mar 2015 2014 FY
2012 $1,443,760 01 Jan 2012 31 Dec 2012 10-K 27 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.